Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Genmab Q2 Loss Narrows

Denmark-based Genmab A/S (GNMSF.PK), Wednesday reported second-quarter net loss of 2.1 million Danish krone or 0.05 krone per share, compared to 80.6 million krone or 1.79 krone per share last year.

Net earnings from continuing operations for the quarter was 8.0 million krone or 0.18 krone per share, compared to net loss from continuing operations of 71.4 million krone or 1.59 krone per share last year.

Net revenues for the quarter was 111.6 million krone, up from 83.9 million krone last year.

The company net loss for the first half of 2012 was 71.6 million krone or 1.59 krone per share, compared to 191.8 million krone or 4.27 krone per share last year.

Net loss from continuing operations for the period was 51.8 million krone or 1.15 krone per share, compared to 172.7 million krone or 3.84 krone per share last year.

Genmab's revenues for the first half period grew 23 percent to 206 million krone from 167 million krone in the prior year period, driven mainly by higher Arzerra royalties and the achievement of a milestone under our collaboration with GlaxoSmithKline.

Click here to receive FREE breaking news email alerts for Genmab A/S and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.